Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy

por Griffiths, R W, Gilham, D E, Dangoor, A, Ramani, V, Clarke, N W, Stern, P L, Hawkins, R E
Publicado 2005

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study

por Valle, J W, Dangoor, A, Beech, J, Sherlock, D J, Lee, S M, Scarffe, J H, Swindell, R, Ranson, M
Publicado 2005

The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication

por Hooper, C E, Lyburn, I D, Searle, J, Darby, M, Hall, T, Hall, D, Morley, A, White, P, Rahman, N M, De Winton, E, Clive, A, Masani, V, Arnold, D T, Dangoor, A, Guglani, S, Jankowska, P, Lowndes, S A, Harvey, J E, Braybrooke, J P, Maskell, N A
Publicado 2015

The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial

por Arnold, D T, Hooper, C E, Morley, A, White, P, Lyburn, I D, Searle, J, Darby, M, Hall, T, Hall, D, Rahman, N M, De Winton, E, Clive, A, Masani, V, Dangoor, A, Guglani, S, Jankowska, P, Lowndes, S A, Harvey, J E, Braybrooke, J P, Maskell, N A
Publicado 2015